ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Votes No To Funding Diet FIT, Citing NCI Resources

December 8, 1989

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

August 25, 1978

DCBD Board Okays New Program Projects For Diagnosis Research

June 7, 1985

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

Guttmacher Named NICHD Director

December 18, 2009